TherapeuticsMD has agreed to pay a fine to settle charges from the U.S. Securities and Exchange Commission.
The SEC charged the Boca Raton-based pharmaceuticals developer (Nasdaq: TXMD) with selectively sharing information with the public that it had shared with research analysts, violating Regulation Fair Disclosure.
The regulator alleged that, on two occasions in 2017, TherapeuticsMD shared information with analysts who could influence the sale of its stock about interactions with the U.S. Food…
